Vimarsana.com

Latest Breaking News On - Lp 1 agonist - Page 1 : vimarsana.com

NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc.

NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities...

China
New-york
United-states
Chinese
Phillip-kim
Laurence-rosen
Nasdaq
Linkedin
Altimmune-inc
Securities-class-action-services
Facebook
Twitter

Popular Weight-Loss Drugs May Cause Gastrointestinal Problems

Diabetic drugs like GLP-1 agonists (semaglutide or liraglutide) used as weight-loss drugs, increase the risk of gastrointestinal problems.

United-kingdom
British
University-of-british-columbia
British-columbia
Weight-loss-drugs-linked
Gastrointestinal-illnesses
Weight-loss
Ype-2-diabetes
Lp-1-agonist
Emaglutide
Iraglutide

FDA warning on compounded versions of diabetes, weight loss drugs

Semaglutide is FDA-approved as Ozempic and Rybelsus to treat type 2 diabetes and as Wegovy to treat overweight and obesity.

Fda-warning
Lp-1-agonist
Zempic
Zempic-and-rybelsus
Ybelsus
Egovy
Besity
Verweight
Emaglutide
Emaglutide-for-diabetes
Ype-2-diabetes

Global Glucagon-like Peptide 1 (GLP-1) Market Analysis

Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus...

United-states
Dublin
Ireland
America
Asia-pacific
Eli-lilly
Novo-nordisk
Shanghai-benemae-pharmaceutical-corporation
Route-of-administration-injectable
Pfizer-inc
Synthorx-inc
Jiangsu-hansoh-pharmaceutical-group-co-ltd

vimarsana © 2020. All Rights Reserved.